Verisk to Announce Fiscal Fourth-Quarter 2019 Results on February 18, 2020
JERSEY CITY, N.J., Jan. 28, 2020 (GLOBE NEWSWIRE) — Verisk (Nasdaq:VRSK), a leading data analytics provider, will report its financial […]
Wintrust Financial Corporation Announces Executive Officer Promotions
ROSEMONT, Ill., Jan. 28, 2020 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust” or the “Company”) (Nasdaq: WTFC) today announced that […]
First Citizens BancShares Reports Earnings for Fourth Quarter 2019
RALEIGH, N.C., Jan. 28, 2020 (GLOBE NEWSWIRE) — First Citizens BancShares Inc. (BancShares) (Nasdaq: FCNCA) reported strong earnings for the […]
Stryker reports 2019 results and 2020 outlook
Kalamazoo, MI, Jan. 28, 2020 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year […]
Meridian Bancorp, Inc. Reports Record Fourth Quarter and Record Full Year Net Income, Up 38% and 20% from Prior Year Periods
BOSTON, Jan. 28, 2020 (GLOBE NEWSWIRE) — Meridian Bancorp, Inc. (the “Company” or “Meridian”) (NASDAQ: EBSB), the holding company for […]
eGain to Announce Fiscal 2020 Second Quarter Financial Results on February 6, 2020
SUNNYVALE, Calif., Jan. 28, 2020 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), the leading provider of omnichannel customer engagement solutions, will announce […]
LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2020
Record Second Quarter Revenue of $61 million, increased 5% year over yearSecond Quarter Adjusted EBITDA Increased 82%Reiterates Fiscal 2020 Guidance […]
Satsuma Pharmaceuticals Announces Publication of STS101 Phase 1 Clinical Trial Results in HEADACHE: The Journal of Head and Face Pain
SOUTH SAN FRANCISCO, Calif., Jan. 28, 2020 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, today […]
Establishment Labs Announces Preliminary Results for Fourth Quarter and Full Year 2019; Reports Record Revenue
NEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) — Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on […]
Akcea and Ionis report positive topline phase 2 study results of AKCEA-ANGPTL3-LRx
Favorable safety and tolerability were observedPrimary and multiple secondary endpoints were met with significant reduction in triglyceride levels, additional lipid […]
